Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial.

MLA

Rodríguez, Carmen, et al. “Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial.” Archivos de Bronconeumologia, vol. 58, no. 5, May 2022, pp. 412–17. EBSCOhost, https://doi.org/10.1016/j.arbres.2022.02.007.

APA

Rodríguez, C., Solier, A., Marín, M., Tenes, A., Durán, D., Retegui, A., Muriel, A., Otero, R., Monreal, M., & Jiménez, D. (2022). Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial. Archivos de Bronconeumologia, 58(5), 412–417. https://doi.org/10.1016/j.arbres.2022.02.007

Chicago

Rodríguez, Carmen, Aurora Solier, Marta Marín, Andrés Tenes, Diego Durán, Ana Retegui, Alfonso Muriel, Remedios Otero, Manuel Monreal, and David Jiménez. 2022. “Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial.” Archivos de Bronconeumologia 58 (5): 412–17. doi:10.1016/j.arbres.2022.02.007.